Latest Ratios: P/E Ratio 44.0x · EV/EBITDA 22.4x · ROE 7.1%. (1996–2025 historical series)
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $155.9B | $162.8B | $169.2B | $171.9B | $173.4B | $214.9B | $141.5B | $98.7B | $64.9B | $58.1B | $48.3B |
| Enterprise Value | $169.7B | $176.6B | $184.3B | $185.6B | $188.0B | $235.6B | $157.7B | $101.3B | $73.9B | $68.0B | $59.6B |
| P/E Ratio → | 43.99 | 45.42 | 43.39 | 36.26 | 24.41 | 33.87 | 40.27 | 39.66 | 24.51 | 23.31 | 18.90 |
| P/S Ratio | 6.34 | 6.62 | 7.09 | 7.20 | 6.51 | 7.30 | 6.35 | 5.51 | 3.81 | 3.17 | 2.86 |
| P/B Ratio | 3.00 | 3.10 | 3.42 | 3.21 | 3.46 | 4.76 | 3.56 | 3.26 | 2.30 | 2.20 | 2.09 |
| P/FCF | 29.63 | 30.94 | 31.95 | 29.74 | 23.54 | 30.42 | 26.13 | 29.76 | 18.88 | 19.98 | 16.47 |
| P/OCF | 24.29 | 25.37 | 25.30 | 24.00 | 20.36 | 25.71 | 22.80 | 24.98 | 16.14 | 16.71 | 13.71 |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 7.19 | 7.72 | 7.77 | 7.06 | 8.00 | 7.08 | 5.66 | 4.33 | 3.71 | 3.53 |
| EV / EBITDA | 22.37 | 23.28 | 24.45 | 24.93 | 19.45 | 23.05 | 25.90 | 22.26 | 17.39 | 15.50 | 14.48 |
| EV / EBIT | 33.03 | 39.25 | 37.43 | 34.80 | 25.57 | 30.05 | 33.07 | 29.68 | 23.84 | 21.92 | 21.32 |
| EV / FCF | — | 33.57 | 34.80 | 32.10 | 25.52 | 33.35 | 29.11 | 30.55 | 21.49 | 23.39 | 20.32 |
Margins and return-on-capital ratios measuring operating efficiency
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 60.9% | 60.9% | 59.5% | 58.7% | 60.8% | 61.0% | 56.0% | 55.7% | 55.8% | 55.8% | 55.6% |
| Operating Margin | 20.9% | 20.9% | 21.7% | 22.1% | 28.3% | 27.3% | 19.4% | 18.8% | 18.0% | 17.2% | 17.7% |
| Net Profit Margin | 14.7% | 14.7% | 16.3% | 19.9% | 27.1% | 21.8% | 16.4% | 14.3% | 15.5% | 13.6% | 15.1% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 7.1% | 7.1% | 7.6% | 9.2% | 15.1% | 15.1% | 10.4% | 8.7% | 9.7% | 10.1% | 10.9% |
| ROA | 4.5% | 4.5% | 4.8% | 5.6% | 8.6% | 8.1% | 5.3% | 4.7% | 5.6% | 5.4% | 5.5% |
| ROIC | 5.9% | 5.9% | 5.9% | 6.0% | 8.7% | 9.9% | 7.3% | 7.2% | 6.3% | 6.7% | 6.4% |
| ROCE | 7.0% | 7.0% | 7.1% | 6.9% | 10.0% | 11.2% | 6.8% | 6.7% | 7.2% | 7.8% | 7.4% |
Solvency and debt-coverage ratios — lower is generally safer
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.35 | 0.35 | 0.35 | 0.37 | 0.41 | 0.52 | 0.56 | 0.74 | 0.35 | 0.40 | 0.53 |
| Debt / EBITDA | 2.43 | 2.43 | 2.28 | 2.62 | 2.13 | 2.28 | 3.64 | 4.95 | 2.29 | 2.40 | 2.98 |
| Net Debt / Equity | — | 0.26 | 0.30 | 0.26 | 0.29 | 0.46 | 0.41 | 0.09 | 0.32 | 0.38 | 0.49 |
| Net Debt / EBITDA | 1.82 | 1.82 | 2.00 | 1.84 | 1.51 | 2.02 | 2.65 | 0.57 | 2.11 | 2.25 | 2.75 |
| Debt / FCF | — | 2.62 | 2.85 | 2.36 | 1.98 | 2.93 | 2.98 | 0.79 | 2.60 | 3.40 | 3.86 |
| Interest Coverage | 16.97 | 16.97 | 17.71 | 18.45 | 35.52 | 32.53 | 17.47 | 31.44 | 22.64 | 19.06 | 15.16 |
Short-term solvency ratios and asset-utilisation metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.87 | 1.87 | 1.40 | 1.68 | 1.89 | 1.43 | 1.86 | 5.19 | 1.47 | 1.43 | 0.97 |
| Quick Ratio | 1.51 | 1.51 | 1.05 | 1.37 | 1.56 | 1.09 | 1.55 | 4.86 | 1.13 | 1.05 | 0.72 |
| Cash Ratio | 0.68 | 0.68 | 0.31 | 0.71 | 0.71 | 0.32 | 0.82 | 4.04 | 0.16 | 0.13 | 0.14 |
| Asset Turnover | — | 0.29 | 0.31 | 0.28 | 0.32 | 0.35 | 0.29 | 0.29 | 0.36 | 0.39 | 0.37 |
| Inventory Turnover | 3.86 | 3.86 | 4.15 | 3.80 | 3.78 | 4.16 | 4.28 | 4.87 | 4.62 | 4.40 | 4.39 |
| Days Sales Outstanding | — | 58.13 | 67.11 | 70.85 | 69.38 | 67.45 | 78.79 | 66.60 | 66.62 | 70.13 | 68.88 |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | 0.6% | 0.5% | 0.5% | 0.5% | 0.5% | 0.3% | 0.4% | 0.5% | 0.7% | 0.7% | 0.8% |
| Payout Ratio | 24.3% | 24.3% | 19.7% | 17.2% | 11.3% | 11.5% | 16.9% | 20.6% | 16.3% | 15.2% | 15.7% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | 2.3% | 2.2% | 2.3% | 2.8% | 4.1% | 3.0% | 2.5% | 2.5% | 4.1% | 4.3% | 5.3% |
| FCF Yield | 3.4% | 3.2% | 3.1% | 3.4% | 4.2% | 3.3% | 3.8% | 3.4% | 5.3% | 5.0% | 6.1% |
| Buyback Yield | 2.0% | 1.9% | 3.5% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Total Shareholder Yield | 2.5% | 2.4% | 4.0% | 0.5% | 0.5% | 0.3% | 0.4% | 0.5% | 0.7% | 0.7% | 0.8% |
| Shares Outstanding | — | $711M | $737M | $743M | $737M | $737M | $719M | $726M | $710M | $706M | $700M |
Includes 30+ ratios · 30 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying DHR stock.
Danaher Corporation's current P/E ratio is 44.0x. The historical average is 21.4x. This places it at the 97th percentile of its historical range.
Danaher Corporation's current EV/EBITDA is 22.4x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 13.5x.
Danaher Corporation's return on equity (ROE) is 7.1%. The historical average is 13.8%.
Based on historical data, Danaher Corporation is trading at a P/E of 44.0x. This is at the 97th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
Danaher Corporation's current dividend yield is 0.56% with a payout ratio of 24.3%.
Danaher Corporation has 60.9% gross margin and 20.9% operating margin. Operating margin above 20% indicates strong pricing power and cost efficiency.
Danaher Corporation's Debt/EBITDA ratio is 2.4x, indicating moderate leverage. A ratio between 2-4x is manageable but warrants monitoring.
Key Metrics
Top Statement Risk
Goodwill impairment risk
Metrics are mathematically derived from official filings.
Margin Resilience Amid Mix Shifts
Danaher's gross margin has held above 57% over the past ten quarters, with operating margin at 18.0% in 2026Q2, according to recent financial statements, indicating pricing power despite revenue mix changes.
The 57.6% gross margin in 2026Q2, while down from the 66.6% peak in 2025Q2, remains robust and suggests the company can maintain pricing in its diagnostics and life sciences segments. Operating margin compression to 18.0% from 22.6% in the prior quarter appears tied to acquisition-related costs and product mix, but the absolute level still exceeds many industrial peers. Net margin of 13.9% in 2026Q2, though below the 17.5% seen in 2025Q4, reflects non-operating volatility rather than a deterioration in core earning power.
ROIC Dip Reflects Acquisition Timing
ROIC fell to 1.2% in 2026Q2 from 2.0% in 2024Q4, as reported in Danaher's financial statements, suggesting that the recent $9.8 billion acquisition has yet to contribute earnings.
The sharp decline in quarterly ROIC, from 2.0% in 2024Q4 to 1.2% in 2026Q2, is consistent with a debt-funded acquisition that has not yet generated returns. On a trailing basis, ROIC remains below the 7-8% levels seen in prior years, but this is likely a temporary effect of the M&A cycle. Investors should monitor whether ROIC recovers as the acquired business is integrated, as sustained sub-2% returns would signal capital allocation concerns.
Working Capital Stretch Signals Supplier Leverage
Danaher's cash conversion cycle extended to 95 days in 2026Q2 from 87 days in 2024Q4, based on reported figures, driven by higher inventory days and slower collections.
The CCC increase is primarily due to DIO rising to 101 days from 90 days, while DSO remained stable at 57 days. This suggests inventory build-up, possibly ahead of new product launches or supply chain disruptions, which ties up cash. DPO of 62 days indicates Danaher is stretching supplier payments, but the net effect is a modest drag on working capital efficiency. The trend warrants monitoring as prolonged inventory holding could pressure free cash flow.
Leverage Spike from Debt-Funded M&A
Danaher's D/E rose to 0.50 in 2026Q2 from 0.35 in 2024Q4, while D/EBITDA jumped to 23.57, according to recent SEC filings, reflecting the $9.8 billion acquisition.
The leverage increase is a direct result of the acquisition financing, with total debt rising to $26.6 billion. The D/EBITDA of 23.57 is elevated, but this is based on quarterly EBITDA annualized, which may understate the full-year figure. Interest coverage of 10.53x in 2026Q2, though down from 25.96x in 2025Q4, remains comfortable, suggesting debt service is not yet a concern. However, the rapid increase in leverage warrants monitoring, especially if the acquired business underperforms.
Liquidity Buffer Thins Despite Ratio Strength
Current ratio improved to 1.65 in 2026Q2 from 1.40 in 2024Q4, but cash dropped to $4.3 billion, as reported in Danaher's balance sheet, indicating a tighter cash buffer.
The current ratio improvement is driven by increased receivables and inventory, not by a stronger cash position. Cash declined from $2.1 billion in 2024Q4 to $4.3 billion in 2026Q2, but this is misleading as the 2024Q4 figure was unusually low; the 2026Q2 cash balance is still modest relative to the $26.6 billion debt. The quick ratio of 1.25 in 2026Q2, down from 1.51 in 2025Q4, suggests that inventory is becoming a larger component of current assets, which could be a concern if demand softens.
P/E Misleads on Acquisition-Driven Growth
Danaher's trailing P/E of 39.69 appears expensive, but forward P/E of 23.55, based on reported figures, suggests the market expects earnings growth from recent acquisitions.
The wide gap between trailing and forward P/E indicates that the market is pricing in a significant earnings recovery, likely from the $9.8 billion acquisition. However, this multiple can be misleading because Danaher's earnings are volatile due to non-operating items and acquisition-related charges. A more appropriate metric is EV/EBITDA, which at 20.36x is more comparable to peers like Thermo Fisher (22.51x) and Waters (28.01x). Investors should focus on organic growth and ROIC rather than P/E alone, as the latter may overstate the cost of the stock.